Israel | Neopharm Group

Sativex® receives regulatory approval in Israel

June 13, 2012

Neopharm Group and GW Pharmaceuticals plc announced that Sativex® (Delta-9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) oromucosal spray) has received regulatory approval from the Israeli Ministry of Health for the treatment of spasticity and neuropathic pain due…

Neopharm Receives Platinum Ratings in Maala CSR Index for 2012

Neopharm Group is proud to announce that it has received platinum ratings for its CSR (Corporate Social Responsibility) activities from Maala CSR Index, which is an index rating companies in CSR since 2003. The ratings…

Neopharm Group Donates 70 Trees Commemorating its 70th...

February 28, 2012

Neopharm Group‘s management and employees have donated and planted 70 trees at Ben-Shemen forest. This donation to the Jewish National Fund is a part of Neopharm’s activities commemorating the 70th anniversary. The planting of the…

Neopharm Israel’s Durex Viral Campaign for World AIDS Day...

January 22, 2012

Neopharm Israel’s Durex “Save the Bulbul” Viral campaign, promoting safe sex for 2011 World AIDS day, gains recognition winning the creative campaign of the year award in the “Extreme Concept” advertising competition. The competition held…

Sativex® receives regulatory approval in Israel

Neopharm Receives Platinum Ratings in Maala CSR Index for 2012

Neopharm Group Donates 70 Trees Commemorating its 70th...

Neopharm Israel’s Durex Viral Campaign for World AIDS Day...

Group Companies